Priority Date: 24.06.10 (KR 20100060196)

RECOMBINANT VECTOR FOR SUPPRESSING PROLIFERATION OF HUMAN PAPILLOMAVIRUS CELL INCLUDING ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 1 (PITUITARY) GENE AND PHARMACEUTICAL COMPOSITION FOR TREATING HUMAN PAPILLOMAVIRUS

  • Application ID: EP11798393
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1974
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 24.06.2010 - Priority Date (KR 20100060196)
  • 29.12.2011 - Publication A2 (WO2011162558)
  • 01.05.2013 - Publication A2 (EP2586865)